1. Isolated colonic epithelial cells of the rat were incubated for 40 min with [6-14C]
glucose and n-[1-14C]
butyrate in the presence of 0.1-2.0 mmol/l
NaHS, a concentration range found in the human colon. Metabolic products, 14CO2,
acetoacetate,
beta-hydroxybutyrate and
lactate, were measured and injury to cells was judged by diminished production of metabolites. 2. Oxidation of
n-butyrate to CO2 and
acetoacetate was reduced at 0.1 and 0.5 mmol/l
NaHS, whereas
glucose oxidation remained unimpaired. At 1.0-2.0 mmol/l
NaHS,
n-butyrate and
glucose oxidation were dose-dependently reduced at the same rate. 3. To bypass
short-chain acyl-CoA dehydrogenase activity necessary for
butyrate oxidation, ketogenesis from crotonate was measured in the presence of 1.0 mmol/l
NaHS. Suppression by sulphide of ketogenesis from crotonate (-10.5 +/- 6.1%) compared with control conditions was not significant, whereas suppression of ketogenesis from
n-butyrate (-36.00 +/- 5.14%) was significant (P = < 0.01). Inhibition of
FAD-linked oxidation was more affected by
NaHS than was
NAD-linked oxidation. 4.
L-Methionine (5.0 mmol/l) significantly redressed the impaired beta-oxidation induced by
NaHS.
Methionine equally improved CO2 and
ketone body production, suggesting a global reversal of the action of sulphide. 5. Sulphide-induced oxidative changes closely mirror the impairment of beta-oxidation observed in colonocytes of patients with
ulcerative colitis. A hypothesis for the disease process of
ulcerative colitis is that sulphides may form persulphides with
butyryl-CoA, which would inhibit cellular
short-chain acyl-CoA deHydrogenase and beta-oxidation to induce an energy-deficiency state in colonocytes and mucosal
inflammation.